ViroGates Corporate Profile 


ViroGates is an international in-vitro prognostics/diagnostics company focusing on monitoring people’s health status. We are devoted to developing biomarkers into affordable healthcare solutions that will serve to prevent and optimize treatment in order for people all around the world to live longer, better lives.

Our first commercial product, suPARnostic, provides a novel method for monitoring the state of an individual’s health by measuring the level of overall immune activation. The technology involves the measurement of the natural human blood protein, V-suPAR, whose elevated levels are indicative of poor prognosis and/or disease outcome.

Established in 2001, we are 10 people working at the headquarters in Medicon Valley, Copenhagen, today. With subsidiaries in South Africa, Singapore and India and a network of distributors throughout Europe, we are driven by a constant goal: To monitor global health. We are committed to continue to deliver ground-breaking research and innovative technologies in order to pursue our mission to save and improve the lives of people globally.